argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
30 jun 2023 - 15:46
Statutory name
argenx SE
Title
argenx and Zai Lab Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
Date last update: 20 October 2026